CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
71.22
+1.03 (1.47%)
Jul 21, 2026, 12:47 PM EDT - Market open
CG Oncology Revenue
CG Oncology had revenue of $1.08M in the quarter ending March 31, 2026, with 1,982.69% growth. This brings the company's revenue in the last twelve months to $5.07M, up 666.01% year-over-year. In the year 2025, CG Oncology had annual revenue of $4.04M with 254.70% growth.
Revenue (ttm)
$5.07M
Revenue Growth
+666.01%
P/S Ratio
1,235.63
Revenue / Employee
$35,711
Employees
142
Market Cap
6.28B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.04M | 2.90M | 254.70% |
| Dec 31, 2024 | 1.14M | 935.00K | 458.33% |
| Dec 31, 2023 | 204.00K | 13.00K | 6.81% |
| Dec 31, 2022 | 191.00K | -10.17M | -98.16% |
| Dec 31, 2021 | 10.36M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PTC Therapeutics | 827.11M |
| Mirum Pharmaceuticals | 569.61M |
| Ligand Pharmaceuticals | 274.48M |
| Xenon Pharmaceuticals | 7.50M |
| Dianthus Therapeutics | 1.34M |
CGON News
- 20 days ago - CG Oncology Slides: Investor presentation - Filings
- 22 days ago - CG Oncology Slides: Conference presentation - Filings
- 26 days ago - CG Oncology 1.15M share Block Trade priced at $66.87 - TheFly
- 26 days ago - CG Oncology 1.15M share Block Trade; price range $66.87-$67.87 - TheFly
- 5 weeks ago - CG Oncology Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - CG Oncology Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - CG Oncology to Present at Upcoming Investor Conferences in June - GlobeNewsWire
- 2 months ago - CG Oncology announces departure of president, COO Ambaw Bellete - TheFly